1) Vulnerable subject
弱势受试者
3) subject
[英]['sʌbdʒikt] [美]['sʌbdʒɪkt]
受试者
1.
Study on Legal Protection of Subject s Right of Informed Consent in Clinical Trial;
对临床试验中“受试者知情同意权”法律保护的研究
2.
Moreover,we claim that for the purpose of scientific and reliable clinical research,the legal rights of subjects and the quality increase of ethics censorship,it is necessary to establish complete ethics censorship procedure and standard,intensify the training of the ethics committee s members,set up supervisory system and promote international comm.
对我国目前药物临床试验伦理审查存在的问题进行了分析,并提出通过建立完善的伦理审查程序和审查标准,加强伦理委员会成员的培训,加大国际间的交流及监管力度等措施,提高伦理审查的质量和水平,以保障受试者的合法权益和临床研究的科学性和可靠性。
3.
In view that clinical trial is different from traditional medical treatment procedure,the existing system is inadequate in protecting subjects safety and legal rights.
鉴于临床试验异于常规的特点,目前的体制不足以保护临床试验受试者的权益。
4) subjects
[英]['sʌbdʒikt] [美]['sʌbdʒɪkt]
受试者
1.
According to valid law,injuries of subjects in clinical trials can only be judged by the principle of fault responsibility.
根据现行法律,临床试验中受试者受到损害只能适用过错责任归责原则。
5) disadvantaged labour group
弱势劳动者群体
1.
The issue of disadvantaged groups has become prominent in the period of socio-economic transformation in China today,but the problem of disadvantaged labour groups should merit more attention.
弱势群体问题是当前我国转型时期的突出问题 ,而弱势劳动者群体问题更值得我们关注。
6) healthy volunteers
健康受试者
1.
Pharmacokinetic study of palonosetron in Chinese healthy volunteers;
我国健康受试者体内帕洛诺司琼的药物动力学研究
2.
OBJECTIVE To study the pharmacokinetics of cyclosporin A (CsA) with or without combination with berberine hydrochloride(Ber) in healthy volunteers.
目的 :研究健康受试者合用盐酸黄连素 (berberinehydrochloride ,Ber)前后环孢素A(cyclosporinA ,CsA)的动力学过程 ,以分析两药相互作用发生的部位。
补充资料：弱弱联合
弱弱联合是指两个总体实力都不强但都拥有自己独特的某方面优势的企业之间进行联合，以形成较强的实力。弱弱联合，弱企业之间优势互补，可以形成整体实力变强的效应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条